Nasal Glucagon

glucagon · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Nasal Glucagon, covering 2016-10-10 to 2024-05-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 Diabetes [Phase 1]